Patent · US Active

Use of PPAR agonists for the treatment of congestive heart failure

US7601863B2 · kind B2 · utility

0Cited by

2References

1Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Wolfgang Linz · Mainz, DE
Stefan Schaefer · Wetzlar, DE
Eugen Falk · Frankfurt am Main, DE
Hans-Ludwig Schaefer · Frankfurt am Main, DE

Key dates

Filing date	Jun 14, 2007
Grant date	Oct 13, 2009
Priority date	—
Expiry date	Jun 14, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention describes the use of PPAR agonists of the formulae (I) or (II)for the treatment of congestive heart failure (CHF).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.